Across TCGA pan-cancer cohorts, DSCAML1 Mutation is linked to patient survival in 14 of 34 cancer types, making it a survival-associated DSCAML1 data layer compared with 25 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher DSCAML1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated DSCAML1 expression acts as an unfavorable survival marker, although some lineages such as STAD and UCEC show a favorable association.
KIRP, KIRC, and STAD are the cancer types where DSCAML1 Mutation most reproducibly stratifies survival.
Mutation survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.